Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 21, 2000, Pages 11575-11580

  Shen, Sanbing ^a   Spratt, Christopher ^a   Sheward, W John ^a   Kallo, Imre ^b   West, Katrine ^a   Morrison, Christine F ^a   Coen, Clive W ^b   Marston, Hugh M ^a   Harmar, Anthony J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; PRIMER DNA; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL TISSUE; CARBOXY TERMINAL SEQUENCE; CIRCADIAN RHYTHM; CONFERENCE PAPER; LACTOSE OPERON; LIGHT DARK CYCLE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPORTER GENE; SUPRACHIASMATIC NUCLEUS; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALIA; INFLUENZA VIRUS; MUS MUSCULUS; RODENTIA;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOMES, ARTIFICIAL, YEAST; CIRCADIAN RHYTHM; DNA PRIMERS; HUMANS; LAC OPERON; MICE; MICE, TRANSGENIC; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; SUPRACHIASMATIC NUCLEUS;

EID: 0034633402     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.97.21.11575     Document Type: Article

References (38)

1. Mikkelsen, J. D. & Fahrenkrug, J. (1994) Brain Res. 656, 95-107.
2. Loren, I., Emson, P. C., Fahrenkrug, J., Bjorklund, A., Alumets, J., Hakanson, R. & Sundler, F. (1979) Neuroscience 4, 1953-1976.
3. Tanaka, M., Ichitani, Y., Okamura, H., Tanaka, Y. & Ihata, Y. (1993) Brain Res. Bull. 31, 637-640.
4. Ibata, Y., Tanaka, M., Ichitani, Y., Takahashi, Y. & Okamura, H. (1993) Neuroreport 4, 128-130.
5. Shinohara, K., Tominaga, K., Isohe, Y. & Inouye, S. T. (1993) J. Neurosci. 13, 793-800.
6. Yang, J., Cagampang, F. R., Nakayama, Y. & Inouye, S. I. (1993) Mol. Brain Res. 20, 259-262.
7. Albers, H. E., Stopa, E. G., Zoeller, R. T., Kauer, J. S., King, J. C., Fink, J. S., Mobtaker, H. & Wolfe, H. (1990) Mol. Brain Res. 7, 85-89.
8. Piggins, H. D., Antle, M. C. & Rusak, B. (1995) J. Neurosci. 15, 5612-5622.
9. Albers, H. E., Liou, S. Y., Stopa, E. G. & Zoeller, R. T. (1991) J. Neurosci. 11, 846-851.
10. Gozes, I., Lilling, G., Glazer, R., Ticher, A., Ashkenazi, I. E., Davidson, A., Rubinraut, S., Fridkin, M. & Brenneman, D. E. (1995) J. Pharmacol. Exp. Ther. 273, 161-167.
11. Scarbrough, K., Harney, J. P., Rosewell, K. L. & Wise, P. M. (1996) Am. J. Physiol. 270, R283-R288.
12. Lucas, R. J., Cagampang, F. R., Loudon, A. S., Stirland, J. A. & Coen, C. W. (1998) Neurosci. Lett. 249, 147-150.
13. Peters, R. V., Zoeller, R. T., Hennessey, A. C., Stopa, E. G., Anderson, G. & Albers, H. E. (1994) Brain Res. 639, 217-227.
14. Hannibal, J., Moller, M., Ottersen, O. P. & Fahrenkrug, J. (2000) J. Comp. Neurol. 418, 147-155.
15. Hannibal, J., Ding, J. M., Chen, D.. Fahrenkrug, J., Larsen, P. J., Gillette, M. U. & Mikkelsen, J. D. (1997) J. Neurosci. 17, 2637-2644.
16. Fukuhara, C., Suzuki, N., Matsumoto, Y., Nakayama, Y., Aoki, K., Tsujimoto, G., Inouye, S. I. & Masuo, Y. (1997) Neurosci. Lett. 229, 49-52.
17. Harrington, M. E. & Hoque, S. (1997) Neuroreport 8, 2677-2680.
18. Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., Wank, S. A. & Waschek, J. A. (1998) Pharmacol. Rev. 50, 265-270.
19. Cagampang, F. R. A., Sheward, W. J., Harmar, A. J., Piggins, H. D. & Coen, C. W. (1998) Mol. Brain Res. 54, 108-112.
20. Mackay, M., Fantes, J., Scherer, S., Boyle, S., West, K., Tsui, L. C., Belloni, E., Lutz, E., Van Heyningen, V. & Harmar, A. J. (1996) Genomics 37, 345-353.
21. Schedl, A., Grimes, B. & Montoliu, L. (1995) in Yeast Artificial Chromosoma (YAC) Protocols, ed. Markie, D. (Humana, Totowa, NJ), Vol. 54, pp. 293-306.
22. Provencio, I. & Foster, R. G. (1995) Brain Res. 694, 183-190.
23. Lutz, E. M., Shen, S., Mackay, M., West, K. M. & Harmar, A. J. (1999) FEBS Lett. 458, 197-203.
24. Sheward, W. J., Lutz, E. M. & Harmar, A. J. (1995) Neuroscience 67, 409-418.
25. Usdin, T. B., Bonner, T. I. & Mezey, E. (1994) Endocrinology 135, 2662-2680.
26. Vertongen, P., Schiffmann, S. N., Gourlet, P. & Robberecht, P. (1997) Peptides 18, 1547-1554.
27. Harrington, M. E., Hoque, S., Hall, A., Golombek, D. & Biello, S. (1999) J. Neurosci. 19, 6637-6642.
28. Chen, D., Buchanan, G. F., Ding, J. M., Hannibal, J. & Gillette, M. U. (1999) Proc. Natl. Acad. Sci. USA 96, 13468-13473.
29. von Gall, C., Duffield, G. E., Hastings, M. H., Kopp, M. D., Dehghani, F., Korf, H. W. & Stehle, J. H. (1998) J. Neurosci. 18, 10389-10397.
30. Suzuki, Y., McMaster, D., Huang, M., Lederis, K. & Rorstad, O. P. (1985) J. Neurochem. 45, 890-899.
31. Poulin, P., Suzuki, Y., Lederis, K. & Rorstad, O. P. (1986) Brain Res. 381, 382-384.
32. Martin, J. L., Feinstein, D. L., Yu, N., Sorg, O., Rossier, C. & Magistretti, P. J. (1992) Brain Res. 587, 1-12.
33. Amenta, F., Cavalotti, C., De Michele, M., De Vincentis, G., Rossodivita, A. & Rossodivita, I. (1991) J. Anton. Pharmacol. 11, 285-293.
34. Seki, Y., Suzuki, Y., Baskaya, M. K., Kano, T., Saito, K., Takayasu, M., Shibuya, M. & Sugita, K. (1995) Eur. J. Pharmacol. 275, 259-266.
35. Smith, D. R., Smyth, A. P. & Moir, D. T. (1990) Proc. Natl. Acad. Sci. USA 87, 8242-8246.
36. Smith, D. R., Smyth, A. P., Strauss, W. M. & Moir, D. T. (1993) Mamm. Genome 4, 141-147.
37. Al-Shawi, R., Burke, J., Jones, C. T., Simons, J. P. & Bishop, J. O. (1988) Mol. Cell. Biol. 8, 4821-4828.
38. Straub, S. G. & Sharp, G. W. (1996) J. Biol. Chem. 271, 1660-1668.